here are 4 mass. biotechs making noise at the ash conference so far .
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done. .
share your thoughts
1243 Used Today
254 Used Today
80 Used Today
77 Used Today
110 Used Today
273 Used Today
323 Used Today
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done. .